Top Markets
Coin of the day
Berry Genomics Co.,Ltd Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd

000710
Rang in Aktien #13832
Berry Genomics Co.,Ltd, a genomics and life science company, develops and... Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well as big data services. The company serves various organizations and facilities, including hospitals, research institutions, universities, and enterprises throughout Mainland China, Hong Kong, Macao, Taiwan, Southeast Asia, the Middle East, and Australia. The company was founded in 2010 and is headquartered in Beijing, China.
Aktienkurs
$1.29
Marktkapitalisierung
$456.97M
Veränderung (1 Tag)
-1.22%
Veränderung (1 Jahr)
-38.75%
Land
CN
Handel Berry Genomics Co.,Ltd (000710)

Kategorie

Aktien-Split-Historie für Berry Genomics Co.,Ltd (000710)
Die Aktie Berry Genomics Co.,Ltd (Symbol: 000710) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Sep 01, 2026 statt.
Eine 000710-Aktie, die vor dem Sep 01, 2026 gekauft wurde, entspricht heute 0 000710-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US